Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 21 - Drugs for disorders of the muscular or neuromuscular system
Patents for A61P 21 - Drugs for disorders of the muscular or neuromuscular system (23,287)
03/2012
03/29/2012WO2012039472A1 Drug against central nervous system inflammation
03/29/2012WO2011145909A3 Novel use of panduratin derivatives or an extract of boesenbergia pandurata for promoting muscle mass growth, fighting fatigue, and enhancing exercise performance capability
03/29/2012WO2011108009A3 Process for the preparation of fampridine
03/29/2012US20120077873 Methods of Reducing Blood Lactate Concentration
03/29/2012US20120077830 Caspase inhibitors and uses thereof
03/29/2012US20120076808 Combined antigen and dna vaccine for preventing and treating autoimmune diseases
03/29/2012US20120076792 Antibody selective for a tumor necrosis factor-related apoptosis-inducing ligand receptor and uses thereof
03/28/2012EP2432761A1 Treatment of muscle disease characterized by insulin resistance
03/28/2012EP2432553A2 Liquid dosage forms of isotretinoin
03/28/2012EP1432707B1 Azabicyclic-substituted fused-heteroaryl compounds for the treatment of disease
03/28/2012EP1117689B1 Bone morphogenetic protein antagonists based on the mature protein
03/28/2012CN1668287B Use of 3-deoxyflavonoids in preparing medicine for inhibition of t-lymphocyte activation
03/28/2012CN102395589A Fused pyrrolopyridine derivative
03/28/2012CN102395571A Novel triazine derivative and pharmaceutical composition containing same
03/28/2012CN102085283B Traditional Chinese medicament for treating myositis ossificans
03/28/2012CN101698095B Drug composition liniment or lotion for treating white vein diseases and preparation method thereof
03/28/2012CN101332235B Magnolia bark and processing technique
03/27/2012US8143297 Heterocyclic derivatives as modulators of ion channels
03/27/2012CA2682329C Substituted imidazopyridine derivatives as melanocortin-4 receptor antagonists
03/27/2012CA2470245C Ifnar2 mutants, their production and use
03/22/2012WO2012037083A2 Compositions and method for promoting musculoskeletal repair
03/22/2012WO2012036168A1 Composition for treating muscular dystrophy
03/22/2012WO2012036152A1 High purity heparin and production method therefor
03/22/2012WO2011152618A9 Non-diffusive botulinum toxin causing local muscle paralysis, and purification method thereof
03/22/2012US20120071529 Tetrazole Compounds Which Selectively Modulate The CB2 Receptor
03/22/2012US20120071470 Pharmaceutical composition comprising a renin inhibitor, a calcium channel blocker and a diuretic
03/22/2012US20120071415 Dominant negative mutants of sam68 for use in the treatment of spinal muscular atrophy (sma)
03/22/2012US20120070507 Compositions and Methods for the Treatment of Soft Tissue Injury
03/22/2012US20120070437 Method of identifying compounds that bind baff-r
03/22/2012US20120070407 Therapy for Promoting Cell Growth
03/22/2012DE102010046218A1 Device, useful for treatment of injuries and illnesses of e.g. tendons and ligaments, comprises a layer system with at least three layers respectively comprising identical or different, dimensionally stable and biocompatible hydrogel
03/22/2012DE102010041117A1 Neue substituierte Amino-, Imino-1,2,4 Triazin Derivate New substituted amino, imino-1,2,4 triazine derivatives
03/22/2012CA2811186A1 High purity heparin and production method therefor
03/21/2012EP2431047A1 Muscle repair promoter
03/21/2012EP2429499A2 Method for impregnation with supercrtitical co2
03/21/2012EP1387854B1 Sfrp and peptide motifs that interact with sfrp and methods of their use
03/21/2012CN102382172A Binding agents which inhibit myostatin
03/21/2012CN102382102A Amide compound
03/21/2012CN102379851A Preparation method of cobamamide lyophilized preparation for injection
03/21/2012CN102379843A Levocarnitine pharmaceutical composition for injection
03/21/2012CN101721706B Medicine composition containing matrine class alkaloid, preparation method and pharmaceutical application
03/21/2012CN101007803B Piperazinyl-, piperidinyl- and morpholinyl-derivatives as novel inhibitors of histone deacetylase
03/20/2012US8138335 Carboxylic acid compounds and medicinal compositions containing the same as the active ingredient
03/20/2012US8137689 Transplant/implant device and method for its production
03/20/2012US8137662 Proliferated cell lines and uses thereof
03/15/2012WO2012033070A1 Therapeutic agent for pain
03/15/2012WO2011143152A3 Acth for treatment of amyotrophic lateral sclerosis
03/15/2012US20120065574 Isoform nell-1 peptide
03/15/2012US20120065271 Method of accelerating muscle growth, decreasing fat deposits and improving feed efficiency in livestock animals
03/15/2012US20120065270 Potassium ion channel modulators and uses thereof
03/15/2012US20120065241 Therapeutic compounds for diseases and disorders
03/15/2012US20120065231 Thiophene derivative
03/15/2012US20120065189 Heterocyclic compounds for the treatment of stress-related conditions
03/15/2012US20120065183 Tetrahydro-Pyrido-Pyrimidine Derivatives
03/15/2012US20120065180 Androgen pharmaceutical composition and method for treating depression
03/15/2012US20120065176 Treatment of muscle disease characterized by insulin resistance
03/15/2012US20120065143 Dose and localization of botulinum toxins in skin and muscle
03/15/2012US20120065131 Compositions and methods for topical application and transdermal delivery of an oligopeptide
03/15/2012US20120064625 Nucleic Acids, Polypeptides, Compositions, and Methods for Modulating Apoptosis
03/15/2012US20120064571 Zcytor19 polynucleotides, polypeptides, antibodies and methods of use
03/15/2012US20120064544 Methods of Diagnosing Hypophosphatemic Disorders
03/15/2012US20120064179 Bicarbonate solution for bioavailable magnesium and uses thereof
03/15/2012US20120064091 Dysfunction of the mitochondrial respiratory chain, methods for diagnosis, treatment and follow-up
03/15/2012US20120064062 Inhibitors of bacterial plasminogen activators
03/15/2012US20120063997 Delivery system with scaffolds
03/15/2012CA2809778A1 Therapeutic agent for pain
03/14/2012CN102378757A Pyrimidine compound
03/14/2012CN102370895A Traditional Chinese medicine composition for treating facial paralysis
03/13/2012US8133877 Composition comprising an antisense sequence implicated in the regulation of angiogenesis
03/13/2012CA2503810C Therapeutic agent for fibromyalgia
03/13/2012CA2467159C Use of therapeutic dosages for nitric oxide donors which do not significantly lower blood pressure or pulmonary artery pressure
03/13/2012CA2442854C Hsa-free formulations of interferon-beta
03/13/2012CA2326959C Treatments for spinal muscular atrophy
03/08/2012WO2012030919A2 Composition and method for muscle repair and regeneration
03/08/2012WO2012029994A1 Pharmaceutical composition for prevention and treatment of amyotrophic lateral sclerosis
03/08/2012WO2012029986A1 Antisense nucleic acid
03/08/2012WO2012012300A3 Treatment of the adverse side-effects associated with administration of an anti-hyaluronan agent
03/08/2012WO2011161427A3 Glycoproteins having lipid mobilizing properties and therapeutic uses thereof
03/08/2012WO2011143187A3 Lactoferrin -based biomaterials for tissue regeneration and drug delivery
03/08/2012US20120059042 Method for efficient exon (44) skipping in duchenne muscular dystrophy and associated means
03/08/2012US20120058986 Di-azetidinyl diamide as monoacylglycerol lipase inhibitors
03/08/2012US20120058981 Androgen pharmaceutical composition and method for treating depression
03/08/2012US20120058955 Use of decorine for increasing muscle mass
03/08/2012US20120058946 Compound and method for treating myotonic dystrophy
03/08/2012US20120058938 Nutritional composition inducing a postprandial endocrine response
03/08/2012US20120058189 Process for making a crystalline zilpaterol salt
03/08/2012US20120058132 Treatment of glycogen storage disease type II
03/08/2012US20120058128 Anti- integrin antibodies, compositions, methods and uses
03/08/2012US20120058089 Treatment of organ injuries and burns using placental stem cells
03/08/2012CA2809637A1 Antisense nucleic acids
03/08/2012CA2809374A1 Composition and method for muscle repair and regeneration
03/07/2012EP2424978A1 Compositions and methods for modulating stem cells and uses thereof
03/07/2012EP2424548A1 Use of n²o gas for treating chronic pain
03/07/2012EP2424511A1 Prevention and treatment of sarcopenia
03/07/2012CN102367227A Stable Levocarnitine compound and pharmaceutical composition thereof
03/07/2012CN102366601A Traditional Chinese medicine preparation for treating apoplexia, facial paralysis and hemiplegia
03/07/2012CN102366402A Scopolamine hydrobromide injection and production technology
03/07/2012CN101642461B Drug composition of iguratimod and glucosamine, preparation method and drug application thereof
03/07/2012CN101060794B The use of anti-oxidant compounds for muscle recovery
03/06/2012US8129381 Caspase inhibitors and uses thereof
1 ... 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 ... 233